This study investigates miRNA impact on lung, colorectal, and epithelial
cancers, emphasizing Wnt3’s role in breast tumor growth through WNT
signaling and its influence on mammary stem cells. WNT pathway
inactivation induces drug-insensitive, quiescent states in breast cancer
stem cells, resulting in resistance to multiple drugs.
Tamoxifen-resistant breast carcinoma cells activate both canonical and
noncanonical WNT signaling, with Wnt3a enhancing tamoxifen resistance in
ER+ carcinoma cells. The study also explores breast cancer
immunotherapy, highlighting immune checkpoint blockade targeting
PD-1/PD-L1 and CTLA-4 as promising avenues. Additionally, the study
explores the NOTCH signaling pathways impact on cancer proliferation,
apoptosis, invasion and metastasis. Elevated NOTCH receptor and ligand
expression particularly in aggressive triple negative breast cancer
correlate with poorer treatment outcome, serving as a predictor for
adverse results in breast tumors. The review discusses the relevance of
Notch signaling in therapy resistance and breast cancer recurrence. The
article encapsulates therapeutic advancements targeting the Notch
signaling pathway, weighing merits and demerits in the context of breast
cancer treatment. Our study provides a comprehensive understanding of
the complex interactions within the WNT and Notch signaling pathways in
breast cancer, shedding light on potential therapeutic targets and
strategies for personalized treatment. This research significantly
contributes to the current body of knowledge, offering promise for
improved outcomes in breast cancer patients. The findings underscore the
importance of WNT and Notch signaling modulation in developing effective
therapeutic interventions for breast cancer.